We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Emergency Medicine

Lower Mortality and Complication Rates for Solid-Organ Transplant Patients Treated at Specialized Transplant Centers for Emergency General Surgery

MedXY Editorial Team•Mar 13, 2026•Emergency Medicine
clinical outcomesHealth Systems ResearchPhẫu thuật cấp cứu tổng quátSolid-Organ Transplant

Introduction: The Intersection of Transplantation and Emergency General Surgery

Solid-organ transplant (SOT) recipients represent a unique and growing population within the modern healthcare landscape. As advancements in immunosuppression and surgical techniques have extended the lifespan of these patients, their susceptibility to common conditions—including those requiring emergency general surgery (EGS)—has become a significant clinical focus. Patients with a history of kidney, liver, heart, or lung transplantation present with complex physiological profiles, including chronic immunosuppression, altered surgical anatomy, and a high burden of comorbidities such as cardiovascular disease and chronic kidney disease.

Emergency general surgery in this cohort is fraught with risk. Diagnoses such as acute cholecystitis, appendicitis, or bowel obstruction, which might be routine in the general population, carry a much higher risk of morbidity and mortality in SOT recipients. A central question in health policy and clinical management has been whether these patients should be treated at the nearest capable hospital or if their outcomes are sufficiently improved by transfer to a specialized transplant center. A recent population-based cohort study published in the Annals of Surgery provides critical evidence to resolve this controversy.

Highlights of the Study

1. Mortality Risk in Kidney Transplant Recipients

The study found that kidney transplant patients treated at academic non-transplant centers had a more than 3.5-fold increase in the odds of 30-day mortality compared to those treated at transplant centers.

2. Improved Composite Outcomes Across All Organs

Regardless of the type of organ transplanted (kidney vs. non-kidney), the composite risk of 30-day complications or mortality was significantly higher at non-transplant centers compared to transplant-specific facilities.

3. The Burden of EGS in SOT Patients

With a complication or mortality rate of 31% across the cohort, EGS conditions represent a major health threat to transplant recipients, necessitating optimized care pathways.

Study Design and Methodology

To investigate the association between hospital type and clinical outcomes, researchers conducted a retrospective population-based cohort study using linked administrative data in Ontario, Canada. The study spanned nearly two decades, from April 1, 2002, to December 31, 2021, providing a robust longitudinal view of the surgical landscape.

The study population included adults with a solid-organ transplant who were hospitalized for an emergency general surgery condition. The researchers categorized hospitals into three types: transplant centers, academic non-transplant centers, and community centers. The primary endpoint was 30-day mortality. Secondary endpoints included 90-day mortality, a composite of 30-day complications or mortality, and 30-day readmission rates.

To ensure statistical rigor, the team employed multivariable logistic regression with generalized estimating equations (GEE). This approach accounted for potential confounders and the possibility of repeat hospitalizations within the same patient population, providing a more accurate assessment of the independent effect of the treatment center type.

Key Findings: Does Location Matter?

The study analyzed 2,679 hospitalizations for EGS conditions among SOT recipients. The results revealed a stark contrast in outcomes based on where the care was delivered.

Mortality Disparities

Overall, 30-day mortality was 4% (111 deaths). However, the association between mortality and center type was strongly influenced by the type of transplant. For kidney transplant recipients, the risk of death was significantly higher when treated outside of a transplant center. Specifically, academic non-transplant centers were associated with an adjusted Odds Ratio (aOR) of 3.52 (95% CI: 1.43–8.65, p=0.006) for 30-day mortality compared to transplant centers. Interestingly, for non-kidney transplant recipients (liver, heart, lung), no statistically significant difference in mortality was observed between center types, though this may be influenced by smaller sample sizes or different baseline risks in those groups.

Complications and Morbidity

When looking at the broader composite outcome—which included 30-day complications or mortality—the advantage of transplant centers became even more apparent. Approximately 31% of the total population (821 hospitalizations) suffered from this composite outcome. The study found that for all transplant types, the composite of complications or mortality was significantly higher in most non-transplant center types compared to specialized transplant centers. This suggests that while mortality might be avoided in some cases, the quality of recovery and the prevention of post-operative complications are superior in specialized environments.

Expert Commentary: The Case for Specialized Triage

The findings of Nantais et al. underscore a critical concept in surgical oncology and complex care: the “volume-outcome” relationship and the importance of institutional infrastructure. There are several biological and systemic reasons why transplant centers may offer superior outcomes for EGS patients.

Multidisciplinary Expertise

Transplant centers house dedicated transplant surgeons, nephrologists, hepatologists, and specialized pharmacists who are intimately familiar with the nuances of immunosuppression. In an EGS setting, managing the balance between surgical stress, infection, and the risk of graft rejection requires expert-level titration of medications like tacrolimus or mycophenolate—expertise that may not be readily available in a general academic or community hospital.

Diagnostic and Interventional Support

SOT patients often present with atypical clinical features. For instance, immunosuppression can mask the classic signs of peritonitis or sepsis. Transplant centers are more likely to have radiologists and interventionalists who are experienced in identifying complications specific to transplanted anatomy, such as vascular anastomotic issues or biliary strictures that may mimic or complicate EGS conditions.

Failure to Rescue

The significant difference in mortality for kidney patients at academic centers versus transplant centers suggests that the issue may not be the occurrence of complications, but the “failure to rescue” patients once complications occur. Transplant centers are better equipped with the protocols and specialized ICU support necessary to manage the rapid decline of a medically complex transplant recipient.

Clinical Implications and Conclusion

The implications of this study for health systems are profound. For clinicians in emergency departments and community hospitals, the data suggest that once a solid-organ transplant patient is stabilized, early consultation with a transplant center and potential transfer should be prioritized, especially for kidney transplant recipients.

From a policy perspective, these findings advocate for the development of formal “hub-and-spoke” models for EGS care in the SOT population. By centralizing the management of these high-risk patients in centers with specialized expertise, health systems can significantly reduce avoidable mortality and post-operative morbidity. While the study is limited by its retrospective nature and reliance on administrative data, the magnitude of the risk increase at non-transplant centers provides a compelling argument for specialized care pathways.

In summary, while emergency general surgery is inherently risky for transplant recipients, the location of care is a modifiable factor that can determine survival. Preferential triage to transplant centers should be considered the standard of care to optimize outcomes for this vulnerable patient population.

References

  1. Nantais J, Saskin R, Calzavara A, Kim J, Gomez D, Baxter NN. Transplant Center Treatment in Emergency General Surgery Patients with a Solid-Organ Transplant. Annals of surgery. 2026-03-09. PMID: 41801073.
  2. Hatch Q, et al. The impact of solid organ transplantation on outcomes in emergency general surgery. Journal of Trauma and Acute Care Surgery. 2014.
  3. DiBrito SR, et al. Emergency General Surgery in the Elderly Transplant Recipient. American Journal of Transplantation. 2018.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Rethinking Surgical Quality Metrics: The Role of Operative-to-Nonoperative Management Ratio in Elderly Emergency General Surgery OutcomesThis study analyzes how the balance between operative and nonoperative management in emergency general surgery for older adults relates to their odds of discharge home, proposing ONR as a novel quality benchmark beyond traditional metrics.Sep 15, 2026Unveiling the Impact of Social Determinants of Health Screening: Insights from an 18-Hospital Network ImplementationThis study evaluates the data quality, variability, and clinical outcomes of inpatient social determinants of health screening across 18 hospitals, revealing important disparities and validating the screening tool’s clinical relevanceSep 13, 2026Low-Normal Hemoglobin Concentrations and Clinical Outcomes in Heart Failure: Rethinking WHO Anemia ThresholdsThis review synthesizes current evidence on hemoglobin thresholds in heart failure, highlighting that optimal prognosis is associated with hemoglobin levels higher than WHO anemia cutoffs, with clinical implications for management and iron Aug 29, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Advancements in Heart Failure Management: Insights from the JROADHF and JROADHF-NEXT Registries
This article reviews improvements in heart failure management and outcomes in Japan between 2013 and 2019-21, highlighting increased guideline-based therapy use and enhanced post-discharge care leading to reduced mortality and readmission r
Aug 22, 2026
Exploring the Role of Autoimmune Conditions in Acute Interstitial Pneumonia: Clinical Outcomes and ImplicationsAutoimmune conditions in acute interstitial pneumonia (AIP) are associated with reduced 90-day mortality and better discharge outcomes, indicating distinct clinical trajectories and opportunities for tailored care.Aug 20, 2026
Oral Anticoagulants, Cognition, and Clinical Outcomes in Atrial Fibrillation and Alzheimer’s Disease: Insights from a Swedish Nationwide StudyThis review synthesizes evidence linking NOAC use to slower cognitive decline and improved clinical outcomes in patients with atrial fibrillation and Alzheimer’s disease, highlighting advantages over warfarin and non-use.Aug 13, 2026